Table 1.
References | Type | Description | Diagnosis of NASH |
---|---|---|---|
Matteoni [15] | Diagnosis | Type 1 (steatosis) Type 2 (steatosis + lobular inflammation) Type 3 (steatosis + ballooning) Type 4 (steatosis + fibrosis or steatosis + MDB) |
Type 3 and 4 |
Brunt [20] | Severity | Grade (activity) 1–3 Stage (fibrosis) 1–4a |
Not for diagnosis |
NAFLD activity score (NAS) [21] | Diagnosis | Steatosis 0–3 Inflammation 0–3 Ballooning 0–3 |
Total score is 5 (4) or higher than 5 (4) |
Younossi [23] | Diagnosis | (1) Steatosis + centrilobular ballooning and/or MDB (2) Steatosis + centrilobular pericellular/perisinusoidal fibrosis or bridging fibrosis |
(1) or (2) |
MDB Mallory–Denk bodies
a Stage 1 was particularly classified by Kleiner et al. as a part of NAS (delicate perisinusoidal fibrosis in the perivenular area as 1A, dense perisinusoidal fibrosis in the perivenular area as 1B and detection of portal fibrosis without perisinusoidal fibrosis was defined as 1C.)